Atlas Trials

Altering Lipids for Tolerance of Aromatase Inhibitor Therapy

Clinical trial NCT04268134 · COMPLETED

Trial details

NCT number
NCT04268134
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-07-28
Primary completion
2024-02-27
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.